Novel heteroaryl-substituted arylaminopyridine derivatives as MEK inhibitors
申请人:Goutopoulos Andreas
公开号:US20070287737A1
公开(公告)日:2007-12-13
The invention provides novel heteroaryl-substituted arylaminopyridine derivative MEK inhibitors of Formula (Ia)
Such compounds are MEK inhibitors that are useful in the treatment of hyperproliferative diseases, such as cancer and inflammation. Also disclosed is the treatment of a hyperproliferative disease in mammals, and pharmaceutical compositions containing such compounds.